-
1
-
-
79960671871
-
Clinical application of tumour markers: a review
-
Amayo AA, Kuria JG (2009). Clinical application of tumour markers: a review. East Afr Med J, 86, 76-83.
-
(2009)
East Afr Med J
, vol.86
, pp. 76-83
-
-
Amayo, A.A.1
Kuria, J.G.2
-
2
-
-
0019427959
-
Elevated levels of circulating carcinoembryonic antigen in hypothyroidism
-
Amino N, Kuro R, Yabu Y, et al (1981). Elevated levels of circulating carcinoembryonic antigen in hypothyroidism. J Clin Endocrinol Metab, 52, 457-62.
-
(1981)
J Clin Endocrinol Metab
, vol.52
, pp. 457-462
-
-
Amino, N.1
Kuro, R.2
Yabu, Y.3
-
3
-
-
80053318958
-
Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review
-
Ballehaninna UK, Chamberlain RS (2011). Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review. Indian J Surg Oncol, 2, 88-100.
-
(2011)
Indian J Surg Oncol
, vol.2
, pp. 88-100
-
-
Ballehaninna, U.K.1
Chamberlain, R.S.2
-
4
-
-
30744470421
-
New tumor markers: CA125 and beyond
-
Bast RC Jr, Badgwell D, LuZ, et al (2005). New tumor markers: CA125 and beyond. Int J Gynecol Cancer, 15, 274-81.
-
(2005)
Int J Gynecol Cancer
, vol.15
, pp. 274-281
-
-
Bast Jr., R.C.1
Badgwell, D.2
Lu, Z.3
-
5
-
-
0034075529
-
Tumor marker measurements in the diagnosis and monitoring of breast cancer
-
Cheung K, Graves CR, Robertson JF (2000). Tumor marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev, 26, 91-102.
-
(2000)
Cancer Treat Rev
, vol.26
, pp. 91-102
-
-
Cheung, K.1
Graves, C.R.2
Robertson, J.F.3
-
6
-
-
34848829608
-
Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters
-
Christoforidis A, Lefkou E, Vlachaki E, et al (2007). Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters. Ann Hematol, 86, 837-41.
-
(2007)
Ann Hematol
, vol.86
, pp. 837-841
-
-
Christoforidis, A.1
Lefkou, E.2
Vlachaki, E.3
-
7
-
-
0026683985
-
Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation
-
Collazos J, Genolla J, Ruibal A (1992). Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation. Int J Biol Markers, 7, 97-102.
-
(1992)
Int J Biol Markers
, vol.7
, pp. 97-102
-
-
Collazos, J.1
Genolla, J.2
Ruibal, A.3
-
8
-
-
33947173790
-
Serum CA-125 is a good predictor of benign disease in patients with postmenopausal ovarian cysts
-
Dikensoy E, Balat O, Ugur MG, Ozkur A, Erkilic S (2007). Serum CA-125 is a good predictor of benign disease in patients with postmenopausal ovarian cysts. Eur J Gynaecol Oncol, 28, 45-7.
-
(2007)
Eur J Gynaecol Oncol
, vol.28
, pp. 45-47
-
-
Dikensoy, E.1
Balat, O.2
Ugur, M.G.3
Ozkur, A.4
Erkilic, S.5
-
9
-
-
79960206891
-
Relationship of CA 19-9 with choledocholithiasis and cholangitis
-
Dogan UB, Gumurdulu Y, Golge N, Kara B (2011). Relationship of CA 19-9 with choledocholithiasis and cholangitis. Turk J Gastroenterol, 22, 171-7.
-
(2011)
Turk J Gastroenterol
, vol.22
, pp. 171-177
-
-
Dogan, U.B.1
Gumurdulu, Y.2
Golge, N.3
Kara, B.4
-
10
-
-
0034968363
-
Clinical uses of tumor markers: a clinical review
-
Duffy MJ (2001). Clinical uses of tumor markers: a clinical review. Crit Rev Clin lab Sci, 38, 225-62.
-
(2001)
Crit Rev Clin lab Sci
, vol.38
, pp. 225-262
-
-
Duffy, M.J.1
-
11
-
-
80055080310
-
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases
-
Escudero JM, Auge JM, Filella X, et al (2011). Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem, 57, 1534-44.
-
(2011)
Clin Chem
, vol.57
, pp. 1534-1544
-
-
Escudero, J.M.1
Auge, J.M.2
Filella, X.3
-
12
-
-
17944399134
-
Alphafetoprotein in hepatic tumours and benign liver diseases
-
Forones NM, Queiroz LA, Ferraz ML, Parise ER (1995). Alphafetoprotein in hepatic tumours and benign liver diseases. Rev Assoc Med Bras, 41, 91-3.
-
(1995)
Rev Assoc Med Bras
, vol.41
, pp. 91-93
-
-
Forones, N.M.1
Queiroz, L.A.2
Ferraz, M.L.3
Parise, E.R.4
-
13
-
-
33947668471
-
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
-
Goonetilleke KS, Siriwardena AK (2007). Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol, 33, 266-70.
-
(2007)
Eur J Surg Oncol
, vol.33
, pp. 266-270
-
-
Goonetilleke, K.S.1
Siriwardena, A.K.2
-
14
-
-
0036789588
-
Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis
-
Harada T, Kubota T, Aso T (2002). Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril, 78, 733-9.
-
(2002)
Fertil Steril
, vol.78
, pp. 733-739
-
-
Harada, T.1
Kubota, T.2
Aso, T.3
-
15
-
-
0038522808
-
A new cause for CA19.9 elevation: heavy tea consumption
-
Howaizi M, Abboura M, Krespine C, et al (2003). A new cause for CA19.9 elevation: heavy tea consumption. Gut, 52, 913-4.
-
(2003)
Gut
, vol.52
, pp. 913-914
-
-
Howaizi, M.1
Abboura, M.2
Krespine, C.3
-
16
-
-
34547765277
-
Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression
-
Kannagi R (2007). Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J, 30, 189-209.
-
(2007)
Chang Gung Med J
, vol.30
, pp. 189-209
-
-
Kannagi, R.1
-
17
-
-
7644220181
-
Management of ovarian cysts
-
Knudsen UB, Tabor A, Mosgaard B, et al (2004). Management of ovarian cysts. Acta Obstet Gynecol Scand, 83, 1012-21.
-
(2004)
Acta Obstet Gynecol Scand
, vol.83
, pp. 1012-1021
-
-
Knudsen, U.B.1
Tabor, A.2
Mosgaard, B.3
-
18
-
-
84866266908
-
Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT
-
Kobeisy MA, Morsy KH, Galal M, et al (2012). Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT. Arab J Gastroenterol, 13, 49-53.
-
(2012)
Arab J Gastroenterol
, vol.13
, pp. 49-53
-
-
Kobeisy, M.A.1
Morsy, K.H.2
Galal, M.3
-
19
-
-
0015359515
-
The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue
-
Krupey J, Wilson T, Freedman SO, Gold P, (1972). The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry, 9, 617-22.
-
(1972)
Immunochemistry
, vol.9
, pp. 617-622
-
-
Krupey, J.1
Wilson, T.2
Freedman, S.O.3
Gold, P.4
-
20
-
-
70350509564
-
Carcinoembryonic antigen screening: how far should we go?
-
Lim YK, Kam MH, Eu KW, (2009). Carcinoembryonic antigen screening: how far should we go?. Singapore Med J, 50, 862-5.
-
(2009)
Singapore Med J
, vol.50
, pp. 862-865
-
-
Lim, Y.K.1
Kam, M.H.2
Eu, K.W.3
-
21
-
-
33846595479
-
ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
-
Locker GY, Hamilton S, Harris J, et al (2006). ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, 5313-27.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5313-5327
-
-
Locker, G.Y.1
Hamilton, S.2
Harris, J.3
-
22
-
-
77957892168
-
Serum markers of hepatocellular carcinoma
-
Malaguarnera G, Giordano M, Paladina I, et al (2010). Serum markers of hepatocellular carcinoma. Dig Dis Sci, 55, 2744-55.
-
(2010)
Dig Dis Sci
, vol.55
, pp. 2744-2755
-
-
Malaguarnera, G.1
Giordano, M.2
Paladina, I.3
-
23
-
-
0023687299
-
Serum levels of CA-50, CA-19-9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung
-
Marechal F, Berthiot G, Deltour G (1988). Serum levels of CA-50, CA-19-9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res, 8, 677-80.
-
(1988)
Anticancer Res
, vol.8
, pp. 677-680
-
-
Marechal, F.1
Berthiot, G.2
Deltour, G.3
-
24
-
-
1842633556
-
The clinical significance of elevated levels of serum CA 19-9
-
Pavai S, Yap SF (2003). The clinical significance of elevated levels of serum CA 19-9. Med J Malaysia, 58, 667-72.
-
(2003)
Med J Malaysia
, vol.58
, pp. 667-672
-
-
Pavai, S.1
Yap, S.F.2
-
25
-
-
0141460669
-
Serum tumor markers
-
Perkins GL, Slater ED, Sanders MD, Prichard JG (2003). Serum tumor markers. Am Fam Physician, 68, 1075-82.
-
(2003)
Am Fam Physician
, vol.68
, pp. 1075-1082
-
-
Perkins, G.L.1
Slater, E.D.2
Sanders, M.D.3
Prichard, J.G.4
-
26
-
-
0347518973
-
The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion
-
Ryu JS, Lee HJ, Cho JH, Han HS, Lee HL (2003). The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion. Respirology, 8, 487-91.
-
(2003)
Respirology
, vol.8
, pp. 487-491
-
-
Ryu, J.S.1
Lee, H.J.2
Cho, J.H.3
Han, H.S.4
Lee, H.L.5
-
27
-
-
46349110598
-
Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers
-
Sajid KM, Chaouachi K, Mahmood R (2008). Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers. Harm Reduct J, 5, 19.
-
(2008)
Harm Reduct J
, vol.5
, pp. 19
-
-
Sajid, K.M.1
Chaouachi, K.2
Mahmood, R.3
-
28
-
-
79751510053
-
Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
-
Serefhanoglu S, Buyukasik Y, Emmungil H, et al (2010). Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia. Int J Med Sci, 8, 30-8.
-
(2010)
Int J Med Sci
, vol.8
, pp. 30-38
-
-
Serefhanoglu, S.1
Buyukasik, Y.2
Emmungil, H.3
-
29
-
-
0024445385
-
CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia
-
Shiota Y, Furuya K, Kitade M, Ueda N, (1989). CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi, 27, 887-93.
-
(1989)
Nihon Kyobu Shikkan Gakkai Zasshi
, vol.27
, pp. 887-893
-
-
Shiota, Y.1
Furuya, K.2
Kitade, M.3
Ueda, N.4
-
30
-
-
13844311017
-
Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency
-
Symeonidis A, Kouraklis-Symeonidis A, Apostolopoulos D, et al (2004). Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency. Oncology, 67, 359-67.
-
(2004)
Oncology
, vol.67
, pp. 359-367
-
-
Symeonidis, A.1
Kouraklis-Symeonidis, A.2
Apostolopoulos, D.3
-
31
-
-
33646703759
-
Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia
-
Symeonidis A, Kouraklis-Symeonidis A, Constantinidou I, et al (2006). Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia. Br J Haematol, 133, 692-4.
-
(2006)
Br J Haematol
, vol.133
, pp. 692-694
-
-
Symeonidis, A.1
Kouraklis-Symeonidis, A.2
Constantinidou, I.3
-
32
-
-
84863916455
-
CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results
-
Szubert M, Suzin J, Wierzbowski T, Kowalczyk-Amico K (2012). CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results. Arch Med Sci, 8, 504-8.
-
(2012)
Arch Med Sci
, vol.8
, pp. 504-508
-
-
Szubert, M.1
Suzin, J.2
Wierzbowski, T.3
Kowalczyk-Amico, K.4
-
33
-
-
81055156135
-
CA-125 and heart failure: reiteration and reappraisal
-
Topatan B, Basaran A, (2011). CA-125 and heart failure: reiteration and reappraisal. Int J Cardiol, 153, 76-8.
-
(2011)
Int J Cardiol
, vol.153
, pp. 76-78
-
-
Topatan, B.1
Basaran, A.2
-
34
-
-
34250753210
-
Tumor markers in pleural effusions
-
Topolcan O, Holubec L, Polivkova V, et al (2007). Tumor markers in pleural effusions. Anticancer Res, 27, 1921-4.
-
(2007)
Anticancer Res
, vol.27
, pp. 1921-1924
-
-
Topolcan, O.1
Holubec, L.2
Polivkova, V.3
-
35
-
-
0036969867
-
Increased serum levels of the tumor marker CA 15-3 on patients with pernicious (Biermer) anemia
-
Triantafillidis JK, Cheracakis P, Konstantellou E, Hyphantis T, (2002). Increased serum levels of the tumor marker CA 15-3 on patients with pernicious (Biermer) anemia. Oncology, 63, 306-7.
-
(2002)
Oncology
, vol.63
, pp. 306-307
-
-
Triantafillidis, J.K.1
Cheracakis, P.2
Konstantellou, E.3
Hyphantis, T.4
-
36
-
-
34848885205
-
Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion
-
Wagner IC, Guimaraes MJ, da Silva LK, de Melo FM, Muniz MT (2007). Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion. J Bras Pneumol, 33, 185-91.
-
(2007)
J Bras Pneumol
, vol.33
, pp. 185-191
-
-
Wagner, I.C.1
Guimaraes, M.J.2
da Silva, L.K.3
de Melo, F.M.4
Muniz, M.T.5
-
37
-
-
0021086375
-
Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure
-
Witherspoon LR, Shuler SE, Alyea K, Husserl FE (1983). Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure. J Nucl Med, 24, 916-21.
-
(1983)
J Nucl Med
, vol.24
, pp. 916-921
-
-
Witherspoon, L.R.1
Shuler, S.E.2
Alyea, K.3
Husserl, F.E.4
-
38
-
-
38749150398
-
Serum tumour markers in patients with chronic kidney disease
-
Xiaofang Y, Yue Z, Xialian X, Zhibin Y (2007). Serum tumour markers in patients with chronic kidney disease. Scand J Clin Lab Invest, 67, 661-7.
-
(2007)
Scand J Clin Lab Invest
, vol.67
, pp. 661-667
-
-
Xiaofang, Y.1
Yue, Z.2
Xialian, X.3
Zhibin, Y.4
-
39
-
-
84863712467
-
Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients
-
Yu H, Li R, Zhang L, et al (2012). Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Exp Diabetes Res, 2012, 745189.
-
(2012)
Exp Diabetes Res
, vol.2012
, pp. 745189
-
-
Yu, H.1
Li, R.2
Zhang, L.3
-
40
-
-
84855283454
-
Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers
-
Yue T, Maupin KA, Fallon B, et al (2011). Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS One, 6, 29180
-
(2011)
PLoS One
, vol.6
, pp. 29180
-
-
Yue, T.1
Maupin, K.A.2
Fallon, B.3
|